Showing posts with label genetic testing. Show all posts
Showing posts with label genetic testing. Show all posts

Wednesday, November 10, 2021

Nov 10, 2021 Chat - Talking to Family and Friends about Cancer and Cancer Risk

We were so happy that Dr Anne Becker-Schutte was able to join twenty-three participants for this robust conversation about Talking to Family and Friends about Cancer and Cancer Risk. You may find the transcript here and the analytics here
 
Here is a summary of the responses to our topic questions. 

T1: After a diagnosis, telling family and friends can be overwhelming. What are some considerations for deciding what information to share, with whom to share it, and when? What are some tips for those early discussions?

  • I recommend that, whenever possible, a patient facing a new cancer diagnosis have at least one trusted person with them at the first appointment, so they have extra ears & a note-taker. 
  • After you take a moment to breathe and digest the information, I encourage direct communication (phone, video, in person) with your most important support people.
  •  If you are a person who processes well in writing, make some notes and consider using a tool like a social media group or CaringBridge page to distribute general information to a larger group (if you have someone who can be in charge of that job, that can be great). 
  • And with kids, you know them best. Most kids will ask for more information if they can handle more. But don’t try to hide it—kids are perceptive. 
  •  It is likely that you will have some shock. Ideally, you will have at least one key support person who can help you hold space and sort out the “who needs to know what” logistics. If not, there are always professional helpers.
  • Ultimately, it is your decision to share how little or as much as you would like. People generally mean well but may not know how to process the unexpected nature of a cancer diagnosis. It is important to know it's your story to share & no one can take that from you. 
  • A1: follow your heart. Let people know what you are comfortable talking about. Talk with your partner about what you are willing to let others do for you

T2: What are some ways to handle the variety of responses and reactions when sharing about one's cancer diagnosis, treatments, and/or experiences?
  • Everyone processes things differently. It's easy to take things personally, however, their response may have nothing to do w/you. If you find it too difficult w/certain people, limit your interactions/information shared. Talk to a therapist to help with processing too.
  • A sad reality is that some who were very close will react by pulling away from the diagnosed person. This is so hard, but know that this is common and others will often step in and surprise you. 
  • I often talk with clients who are struggling with the reactions of others. Some folks pull away. Some folks say insensitive things. Some folks appear to expect you to solve their discomfort over your diagnosis. 
  • I second the suggestion to remember that others are responding to their own issues, even if it feels like responding to you. During diagnosis and treatment, you need to center your energy on your health and your family. 
  • I love that card about "When life gives you lemons, I will not tell you about my friend that died of lemons". Others often don't know what to say and go in weird and hurtful directions.
  • T2 sometimes it’s easier to talk to strangers in a support group who are going thru or have gone thru your journey
  • Yes! A well-run support group (or a space like #gyncsm) can be a huge support because you have that shared experience.
  • A2: I had to be very clear about my main agenda in contacting family members. It wasn’t for support or validation. I’d just tested + for BRCA2 and getting word out to fam was my overriding concern.
T3: What advice would you offer to friends and family when talking to their loved one about cancer? What have you found MOST helpful? What tends to be NOT helpful at all?
  • The first thing I encourage family and friends to do is to avoid trying to say the exact right thing. 
  • In fact, I think that one of the most connecting, caring things you can say if someone shares a diagnosis is, “I am so sorry to hear that. I don’t know exactly what to say, but I want you to know that I am here.” 
  • I also encourage folks to offer a specific type of help. “I will come over on Tuesdays to take the kids to the park. I will walk your dog. I will be there Thursday to run some laundry.” Asking a person who is in treatment what they need can actually create a burden. 
  • Another suggestion I offer to friends and family is to just say, “Tell me if you need me to be cheerful or to just be with you and share the sadness together.” No feeling needs to be solved. Feelings just need acknowledgment & space. 
  • A3: I sometimes point friends and family members to the “ring theory” of responding to tough situations: Comfort in (towards the person who is ill). Dump (your fear, etc) out—to the rest of your support network.
  • I feel something like "I don't know what to say. This is hard." can go a long way vs. trying to say the perfect thing and making it worse and/or not saying anything because so worried. 
  • T3 listen. Ask if you can do errands or chores. Drive to treatment. Wash their hair! 
  • Support is everything. Please don't listen to respond. Listen to listen and provide advice only when asked. Most of us just need someone to hear us. If you are unable to support us, encourage support groups either virtually or at a local infusion center.
  • Love the asking what they are looking for. Sometimes want to talk cancer. Sometimes want to talk anything but cancer. 
  • t3: Show Up. 
  • T3 NOT helpful. "So do you trust what the doctor is telling you? "or " So what caused the cancer?" ( heck if I knew that I'd get the Nobel Prize.) " Oh that's a bad one my Aunt... Sister..., Neighbor had that ."
  • Listen to listen, not to respond.

T4: Many of us struggle with how to ask for and accept help and support. How can we best communicate what we need to friends and family when feeling overwhelmed?
  • For some of my clients, it helps to have a list of the stuff that needs to be done (housework, kids, doctor visits), and allow people who offer help to just choose from the list.
  • I also remind patients that friends and family members can’t take away the cancer, but often are desperate to do something. Offering a concrete need is actually helping the helper.
  • And sometimes we all need the reminder that accepting help is not a failure. It is part of the human experience. I suspect my aunt may have lived longer if she had been able to rest and accept help.
  • A4: The best advice: keep a journal. Write down anything & everything. If you want to talk to someone, ask for a referral from your provider's office. Sometimes you don't know you need help until you're in the process. Remember, healing is not linear.
  • When people w cancer seek & receive help from others, they often find it easier to cope. When you accept help from your loved ones you are allowing them to feel connected to you during a time that they really need to express how much they care about you 
  • Those who care about you won’t know how to best support you & may say “let me know how I can help”. This is a great opportunity to tell them in specific way what they can do to be helpful. It’s important for you and it’s important for them to allow this to happen 
  • This is so hard to do when you are tired, overwhelmed, brainfogged. It’s good to make a list, like in Google docs or something, and share it 

T5: For genetic testing, what are some considerations when it comes to sharing the results with family? Are there resources for how to reach out and for handling their reactions and questions?

  • A5: My first consideration would be to think about what I hope others would share with me. I want to know if I have elevated genetic risk. It’s why I pay attention to my cardiac health.
  • My aunt called me and then sent a follow-up email with information from her genetic counselor. It was good to have things to look at and research when I was ready after that initial conversation. 
  • genetic testing results have implications for you & your medical care, but also the cancer risk & medical recommendations for relatives ... #HereditaryCancer
  • Every family dynamic is different, so what works in one family might not in another - across the board, we recommend that genetic test results are shared with family members, especially if a gene mutation is detected, as relatives may have inherited higher cancer risks
  • Some families will share genetic test results w/ relatives at gatherings (holidays/reunions), some have phone calls, send information to relatives by letter, or invite relatives to join them in a genetic counseling visit #gyncsm Getting the info out is a huge & important 1st step
  • Resources to help w/ sharing genetic test results are available through orgs like @FacingOurRisk & others. A genetic counselor can also help you think though different strategies & answer questions that you may get from relatives.@GeneticCouns has info & how to find a GC 
  • T5 I made sure to ask first before I shared my results with close family members. Some relatives didn’t want to talk about it. When they were ready we did have the discussion. 
  • Organizations like @FacingOurRisk @CancerDotNet @GeneticCouns have resources for sharing genetic results with relatives.
  • T5. I felt it was so important to share with my family. My doctor helped me with the info to share
  • T5 One other issue that a lot of us faced with genetic testing was being told by family and others that it’s “so good you couldn’t have kids to pass that on.” Goes along with the it’s less sad when we die without kids
  • I discussed outreach strategy with my genetic counselor and a peer navigator at FORCE. I knew that, for myself, receiving a form letter about my genetic test results would have turned me off. I would prefer a more personal, one-on-one approach, so that’s what I used 
T6: What are some tips and resources for guiding end of life discussions and planning with friends and family?
  • I like encouraging folks to explore tools like National Healthcare Decision Day or the toolkit at the Center for Practical Bioethics to begin thinking about how to have these conversations.
  • I remind my clients that their discussions and decisions are ultimately their own. These can be guided by family values, religious/spiritual values, etc. but should ultimately reflect your values. 
  • When I worked as a hospital social worker, we shared resources like Death With Dignity: https://deathwithdignity.org/learn/end-of-life-resources/ 
  • They are tough conversations, which is why I have advocated for folks to have these conversations with loved ones long before there is any diagnosis. It’s a regular discussion at my house.
  • I also remind clients that making clear plans about your desired end of life healthcare decisions, burial/cremation arrangements, ceremony or celebration is a gift to those left behind. (Also, having a central location for key paperwork).
  • It can start when making out an advanced directive and health proxy. Be honest with loved ones about our wishes. As family members, we have to be willing to listen to what our loved one wishes and not place our ideas on how they should be coping.
  • 1/3: talking about end of life can be difficult but having open and honest communication with your family will create emotional connection at a time when it is needed most. It is natural to want to protect your loved one and yourself 
  • 2/3: Some people may feel that talking about end of life communicates giving up. In fact, most couples report that sharing their deepest concerns, especially about end of life, brings them closer together and helps them feel less fear
  • 3/3: It is hard to hide fears related to EOL. Not sharing your thoughts may only add to their concerns & sense of being alone. Being deeply honest w them shows courage & commitment & gives them the opportunity to talk w you in a way that may not possible w anyone else 

We look forward to you joining us at the next #gyncsm chat on Wednesday, December 8th at 8pmET when we’ll discuss "Surviving Holiday Stress"

Wishing all a very Happy Thanksgiving. We are thankful for our moderators, supporters, and all participants. "Thanksgiving is also National Family Health History Day... Speaking of sharing and taking with relatives! #gyncsm" E. Bodnar

Dee


Resources




Friday, November 5, 2021

Talking to Family and Friends about Cancer and Cancer Risk- Nov 10 #gyncsm Chat

 


This month on Wednesday, November 10th, at 8pm ET, #gyncsm is pleased to have our very own health moderator, Dr Ann Becker-Schutte (@DrBeckerSchutte) as our guest to discus Talking to Family and Friends about Cancer and Cancer Risk.  
 
How we talk about our cancer with family and friends may change over time as we progress from newly diagnosed, to being in treatment, to survivorship. Those with a gyn cancer or high-risk diagnosis may respond differently to their loved ones' reactions. With genetic testing recommended for all women with ovarian cancer and endometrial cancer, how we share and discuss those results with loved ones is an important consideration. 
 
We invite you to join us as we discuss the following topics questions:
 

T1: After a diagnosis, telling family and friends can be overwhelming . What are some considerations for deciding what information to share, with whom to share it, and when? What are some tips for those early discussions?


T2: What are some ways to handle the variety of responses and reactions when sharing about one's cancer diagnosis, treatments, and/or experiences?


T3: What advice would you offer to friends and family when talking to their loved one about cancer? What have you found MOST helpful? What tends to be NOT helpful at all?

T4: Many of us struggle with how to ask for and accept help and support. How can we best communicate what we need to friends and family when feeling overwhelmed?


T5: For genetic testing, what are some considerations when it comes to sharing the results with family? Are there resources for how to reach out and for handling their reactions and questions?


T6: What are some tips and resources for guiding end of life discussions and planning with friends and family?

Feel free to check the Cancer.Net website for tips on communicating with your spouse/partner, child, and teen about your cancer. 

Christina and I look forward to having you join us.  


Dee 
#gyncsm Co-moderator




Wednesday, September 8, 2021

September 8, 2021 - 8th Anniversary Chat , Genetic Testing and Gyn Cancers

We were pleased to have Meg Farmer (@MegFarmerCGCMBA), Genetic Clinical Operations Director at My Gene Counsel (@MyGeneCounsel) join us on Wednesday September 8, 2021 at 8pm ET to discuss Genetic Testing and Gyn Cancers

Sixteen participants joined us for this important discussion. You may find analytics here and a transcript here. Resources may be found at the end of the post. 

Here is a summary of the responses to our topic questions. 

T1: The topic of genetics and cancer can quickly get confusing. What is genetic testing vs. genomic testing?
  • Genetic (germline) testing looks for hereditary mutations linked with increased risk of cancer. Genomic (somatic) testing looks for mutations in the tumor/cancer that may be useful for targeted cancer treatment 
  • Genetics are what is going on in ALL your cells ( often called germline testing). Genomic testing is specific to the tumor - it can be obtained through tissue or blood! 
  • Study of genes and their roles in inheritance vs. the study of all of a person's genes (the genome), including interactions of those genes with each other and with the person's environment #gyncsm https://www.genome.gov/about-genomics/fact-sheets/Genetics-vs-Genomics 
T2a: Mutations in what genes are known to be associated with ovarian cancer?
  • To start, mutations in many genes are linked with hereditary risk for ovarian cancer. Most people think of #BRCA1 and #BRCA2 first because mutations in these genes account for the most cases of hereditary ovarian cancer.  Other genes linked with hereditary ovarian cancer include #Lynchsyndrome genes, #BRIP1 , #RAD51C , #RAD51D , #PALB2 and more. Importantly not all genes are equal when it comes to level of risk and @NCCN guidelines for risk reducing options. 
T2b: Mutations in what genes are known to be associated with endometrial cancer?
T2c: Are mutations in any genes known to be associated with other gynecologic cancers?
T3a: What types of genetic testing are used to find hereditary reasons for gynecologic cancer?
T3b: Who is recommended to get genetic testing for hereditary gynecologic cancer?
  • To start, according to the @NCCN , #GeneticTesting should automatically be considered for those with epithelial #ovariancancer or #endometrialcancer younger than 50. https://t.co/QVemXGk8Gu https://t.co/2pfMrwwNkR  #GeneticTesting should also be considered if we see following combinations of cancer in one person or branch of a family tree: colon/endometrial/ovarian/other GI cancers or breast/ovarian/prostate/pancreatic cancers. If you’re concerned about hereditary cancer risk based on this or other personal/family cancer history, a #GeneticCounselor can help determine whether genetic testing is appropriate, best person in family to test, and best test. 
  • @asco has this guideline for testing women with an epithelial ovarian cancer dx - Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline https://ascopubs.org/doi/full/10.1200/JCO.19.02960 #gyncsm
  • Every #ovariancancer patient should have genetic testing at the time of diagnosis.
  • Or for patients with endometrial cancer who have abnormal MMR (mismatch repair genes) - genetic testing for Lynch syndrome may be recommended. 
T4a: Do different mutations appear in tumors (genomic testing) than may appear in genetic tests?
  • Yes. All tumors have mutations. Most of these are only in the tumor (somatic) rather than there from birth and usually in all of a person’s cells (germline/hereditary). For every cancer type, there are genes in which we are most likely to see somatic mutations Just like multigene genetic tests are often used now, genomic tests usually test many genes at once too so oncologists have more info to work with when considering how a cancer is behaving and best treatment plans 
T4b: Is genetic testing ever recommended because of genomic test results?
  • To start, yes. There can be clues in somatic test results that a person may actually have a hereditary mutation. For example, if a #BRCA mutation is seen in any tumor type, or if a mutation is seen at a higher level in a tumor than would be expected if just somatic. Your doctor or genetic counselor can help clarify and develop a plan for hereditary genetic testing if such clues come up in somatic testing. Check out this blog on the subject from @InformedDNA #gyncsm https://informeddna.com/somatic-vs-germline-testing/

T5: What are some of the benefits of genetic and genomic testing?
  • To start, genomic (somatic) testing can help oncologists understand how a cancer behaves and potentially identify targeted treatments  #precisionmedicine Genetic (germline) testing can be helpful for those without cancer too if hereditary cancer is suspected in a family. If a mutation is identified, individualized plans can be made for early cancer detection, cancer risk reduction, and family planning.
  • Concerns about #genetictesting , health insurance, life insurance, and other policy types are common. Check out this guide on protections and exceptions of the Genetic Info Non-Discrimination Act (GINA) #gyncsm https://www.jax.org/education-and-learning/clinical-and-continuing-education/ccep-non-cancer-resources/gina-overview#
  • I think the importance of genetic testing after diagnosis is growing and growing - especially with newer treatments like immunotherapy. But all treatments are getting more targeted so knowing the genetic and genomic test results can be key to improved outcomes 
  • Definitely a lot goes into the decision to get tested before or after diagnosis. That's where genetic counselors can be so valuable. There are also wonderful groups like @FacingOurRisk that can help you think through the legal/insurance/etc. issues and beyond. 


We are happy to have celebrated our 8th Anniversary as a Chat and Community during this chat. Thank you for everyone who has helped to support the #gyncsm community these past eight years. 

It is time again for our biennial survey. This survey helps Christina and I plan the coming year's chat topics and, along with our health moderators, provide you the best information in the best format. This link to the community survey will be open until Sept 22 https://www.surveymonkey.com/r/SGD3SDQ . Please take some time to fill out this five minute survey. Thanks!

Note there will be no #gyncsm chat in October. Save the date for our next chat Wed, November 10, 2021 at 8pmET when we’ll discuss “Talking to Family and Friends about Cancer and Cancer Risk”.

See you in November! 

Dee


Resources 
Fact Sheet - Genetics vs Genomics

Who Should Be Concerned About Hereditary Cancer?

NCCN  Know What Your Doctors Know: Ovarian Cancer Part 3 – Genetic Testing

ASCO guideline 

Hereditary Cancer s in Gynecology ...

Patient-Centered Cancer Care: Somatic vs Germline Testing and the Role of Genetic Counselors  https://informeddna.com/somatic-vs-germline-testing/

Thursday, September 2, 2021

Genetic Testing and Gyn Cancer chat - Our 8th Anniversary Chat on the 8th!

 


We are pleased that Meg Farmer (@MegFarmerCGCMBA), Genetic Clinical Operations Director at My Gene Counsel (@MyGeneCounsel) will join us Wednesday September 8, 2021 at 8pm ET (7pm CT, 5pm PT) for our discussion of Genetic Testing and Gyn Cancers

We will discuss the difference between genetic and genomic testing, gene mutations associated with gyn cancers, germline and somatic testing for gynecologic cancers, recommended genetic/tumor  testing for gyn cancers, and how knowledge from the tests can help patients make treatment decisions.

Here's our topic questions:

T1: The topic of genetics and cancer can quickly get confusing. What is genetic testing vs. genomic testing?

T2a: Mutations in what genes are known to be associated with ovarian cancer?
T2b: Mutations in what genes are known to be associated with endometrial cancer?
T2c: Are mutations in any genes known to be associated with other gynecologic cancers?

T3a: What types of genetic testing are used to find hereditary reasons for gynecologic cancer?
T3b: Who is recommended to get genetic testing for hereditary gynecologic cancer?

T4a: Do different mutations appear in tumors (genomic testing) than may appear in genetic tests?
T4b: Is genetic testing ever recommended because of genomic test results?

T5: What are some of the benefits of genetic and genomic testing?

Our September chat will mark our 8th Anniversary as a chat and community. Has it really been 8 years? Seems like yesterday when Christina and I were emailing back and forth with Drs Dizon, Boulay, Markham and Becker-Schutte about starting a gyn cancer community similar to the #bcsm community. 

September also marks the time when we once again invite our community to take a survey. The survey helps Christina and I plan the coming year's chat topics and, along with our health moderators, provide you the best information in the best format. We will share the link to the survey in our after-chat blog post.

All September, which is Gynecologic Cancer Awareness Month (#GCAM), learn more about gyn cancers by following our Twitter posts and those of our supporters, @SGO_org, @IamCervivor and @ocrahope. 

We look forward to seeing you on the 8th. 

Dee and Christina

Wednesday, September 11, 2019

Sept. 11, 2019 Chat - The Breast and Ovarian Cancer Connection

As the #gyncsm community celebrated its' Sixth Anniversary we discussed The Breast and Ovarian Cancer Connection.  We were pleased to have Lisa Schlager from FORCE (@FacingOurRisk) and Joy Larsen Haidle from the National Society Genetic Counselor's (@GeneticCouns)  as well as genetics counselors, survivors, physicians, organizations and advocates join us for this very important discussion.

A complete transcript may be found here and the analytics here.

Here are a few responses to the questions we asked.

T1A: What is hereditary breast and ovarian cancer (HBOC)? Which are the most commonly affected genes in HBOC?

  • A1 HBOC means that there is an inherited risk factor that increases the chance of developing certain cancers over a lifetime such as breast & ovarian cancer. There are several breast/ovarian cancer genes; the most well known are BRCA1 & BRCA2.
  • T1a Cancers that occur because of an inherited genetic mutation are hereditary cancers or HBOC. Cancers that are not due to a hereditary gene change are called sporadic cancer. #gyncsm
  • A1 The chance of developing cancer over a lifetime varies depending on the gene & by gender. Remember inherited cancer predisposition may be inherited from men just as likely as w/ women. Don’t forget the guys in the family! Men have an increased cancer risk too. #gyncsm 
  • T1a Red flags of HBOC include ovarian, early onset breast, male breast, pancreatic or prostate cancer. Also, multiple family members w/cancer and/or Ashkenazi Jewish ancestry. #gyncsm
  • A1a BRCA1/2, PALB2, ATM, and CHEK2 are commonly affected genes in HBOC.Other genes related 2 HBOC include BARD1, BRIP1, RAD51C, RAD51D, EPCAM, CDH1, CHEK2, NBN, MLH1, MSH2, MSH6, PMS2, NF1, PMS2, PTEN, STK11, TP53 #gyncsm


T1B: What information do genetic counselors need to determine risk and the need for women to be tested? #gyncsm

  • A1B Talk with relatives to learn about the health problems that run in the family. For cancer, ask what type & age of onset. Ask if female relatives have had ovaries and/or uterus removed plus the age. Ask about colon polyps too. #gyncsm 
  • A1b Personal & family history of all cancers (2-3 generations) including type & age at diagnosis from the mother’s & father’s side of the family help determine risk & need for genetic testing. #gyncsm
  • A1B Genetic testing is common now. Ask if relatives had genetic testing done & if they would share a copy of the results. Important to share information to help protect health! #gyncsm
  • A1b People w/ Eastern European Jewish ancestry are 10 times more likely to carry a BRCA mutation than the average population. 1:40 vs. 1:400 people.


T2A: What % of women diagnosed with breast cancer have these mutations? What % with ovarian cancer have these mutations?

  • A2a An estimated 10% of #BC and 15-20% of #OVCA are due to an inherited genetic mutation. These numbers are higher in certain populations
  • A2A Up to 10% of women w/ #BC have a strong inherited risk factor. Another 20% of women w/ #BC may have a moderate risk cancer gene. For #ovca, up to 25% of women have an underlying inherited risk. Important to see a GC for a risk assessment & consider testing. #gyncsm 

T2B: Has the number of prophylactic surgeries (surgeries before cancer develops) increased in the past 10 years? Have celebrity stories about their surgeries helped or hindered from your perspective?

  • A2B Celebrity stories created awareness & conversation about options for risk reduction. Words used to describe mastectomy have changed to be more accepting & supportive than past years.
  • Surgical decisions personal & may be influenced by cancer experience in family. Have seen more women ask about bilateral mastectomy in recent to explore all options.
  • T2A: certain types of breast & ovarian cancer have higher % chance of having a hereditary cause such as triple-negative breast cancer (especially if diagnosed before 60yo) & high-grade serous ovarian cancer. A genetic counselor can help assess your risk
  • A2b Genetic testing has increased & national guidelines support risk-reducing surgery for those w/certain mutations so it follows that the numbers of prophylactic surgeries have increased.
  • A2b Celebrity stories have both helped & hindered genetic testing depending on the celebrity & the nature of the story. Angelina Jolie was probably the most positive & influential.


T3A: What options do women with a BRCA mutation (Previvors) have to reduce their risk of the diseases? How will the new USPSTF testing recommendations impact women?

  • A3: There are 3 main options to manage or reduce risk: increased screening, chemoprevention & risk-reducing surgery. #gyncsm https://t.co/AoKQ0eXDy4  
  • A3: The new USPSTF guidelines are nearly identical to those published in 2013. Only addition is consideration of ancestry in evaluating risk & need for testing.
  • A3: The new USPSTF recs fall short of meeting the needs of Americans who may be at increased risk of cancer due to hereditary factors. Check out our statement on the new guidelines.
  • A3 New recs help remind that past hx of #brca important as testing may not been available @ time of diagnosis & criteria broader. Young age (50 or under), bilateral #brca, metastatic brca, triple negative brca, #ovca, #FTca & primary peritoneal all test candidates. #gyncsm
  • A3: USPSTF guidelines ignore men, ignore mutations other than BRCA, & ignore people w/ cancers other than breast or ovarian. They must do better.
  • It's helpful to remember USPSTF has specific parameters and frameworks that they work within--they focus on evaluating high quality evidence for specific populations. Often in hereditary cancer, evidence is poor, out of date, or has gaps -- we have tons more work to do!


T3B: What are the benefits of testing for women already diagnosed with breast or ovarian cancer?

  • Testing post diagnosis #bc or #ovca helpful to determine chance second cancer over lifetime, where, and if should consider risk reduction or extra surveillance. Helps relatives prevent cancer too.
  • Targeted therapies, such as PARP drugs are paving the way for HBOC’s. Progression free survival is making a difference for these women.
  • Testing post diagnosis #bc or #ovca helpful to determine chance second cancer over lifetime, where, and if should consider risk reduction or extra surveillance. Helps relatives prevent cancer too.
  • A3b: Testing may help identify targeted treatments. It also helps inform surgical decisions, risk of other cancers, and potential risk to family members.
  • T3B: Targeted therapy consideration & clinical trial eligibility are increasingly factors that encourage women w/ #breast or #ovarian cancer to seek genetic counseling & genetic testing -- mutation status can guide which treatment or maintenance options may be recommended


T4 What advice can you offer to women with the mutations in how to to share this information with their families?

  • A4 GCs often provide letter to share w/ family explaining inherited risk in the family & how to learn more. Important to share information w/ relatives. Respect different choices w/ how to use results & differing opinions on whether want to know mutation status.
  • A4 If you receive a relative letter, remember the courage it took to send it & the intent to help you learn more if you wish to do so. Talk to a GC to answer your questions. It does not obligate you to test, but instead helps you make an informed choice.
  • Prevention for extended family members by genetic testing is a priceless gift from those previously affected by HBOC. Having options & making life style changes are just a few more extended gifts.
  • Great resources exist to help relatives share results and access "cascade" genetic testing: check out @KintalkUCSF https://t.co/GlpGnGTXbn (a research study offering testing) + many genetic testing laboratories now offering ways to get tested directly
  • FORCE even has a sample letter for sharing info about the mutation with family members and children. We encourage anyone considering testing to seek out a genetic counselor!


T5: If you had genetic testing, what reaction did you have when you learned you had or did not have a BRCA mutation?

  • A5 Many experience fear or sadness, but also a sense of empowerment.
  • I was disappointed I did not have the mutation.Part of me I wanted to explain why I got #ovca . I also thought women with a the mutation has longer survival and more treatment
  • When my family member tested positive, it was an answer to something we knew was going on in the family. It was a relief that is is moderate risk vs high risk. It being moderate and more rare also makes healthcare decision making that much more murky though
  • T5: complex reactions — relieved that my OvCa wasn’t my “fault”; surprised that as an Ashkenazi Jew with a mom who died of breast cancer genetic testing had never been offered to me earlier; I was completely #BRCA-unaware. So I was gobsmacked as they say across the Pond.
  • T5: Pretty much expected to test +, so wasn't shocked. At that point, we were used to getting bad news. Or sorta numb to it. 

Insurance:
Many assume that insurance won't cover genetic testing. Or, they fear insurance repercussions. FORCE has info on legal rights and insurance coverage. We also have sample insurance appeal letters for those who encounter problems with coverage.

We will not be chatting in October but be sure to catch our next #gyncsm chat on Wed Nov 13th when we’ll discuss Stress and Cancer. 


* Announcement *  - It is time for a survey of our #gyncsm community. We hope you will complete the short survey at: https://www.surveymonkey.com/r/FBVD8TN so we can understand our community and support you with the topics that are most beneficial. The survey will be open until September 30, 2019. 


We look forward to seeing you in November. 

Dee
#gyncsm Co-moderator

RESOURCES 

@FORCE  https://www.facingourrisk.org/understanding-brca-and-hboc/information/hereditary-cancer/hereditary-genetics/?subcat_nice_name=hereditary-genetics&tab_type=index

@SHAREing  https://www.sharecancersupport.org/

@GeneticCouns https://www.findageneticcounselor.com/ to locate a genetic counselor near you or by telephone.

CDC Does Breast or Ovarian cancer run in your family ? https://t.co/qQuS4Pr1pW

Facebook: #BRCA Advanced 101 & 102 #JournalClub

Friday, September 6, 2019

Breast and Ovarian Cancer Connections Sept 11,2019 Chat



This month, which is Gynecologic Cancer Awareness Month, we will be chatting about The Breast and Ovarian Cancer Connection. We are so happy that representatives from FORCE (@FacingOurRisk) and The National Society of Genetic Counselors (@GeneticCouns) will be joining us for the very important discussion.

Cancer can be caused by many things. But when a cancer develops because of an inherited mutation, that is called a hereditary cancer. The most common causes of Hereditary Breast and Ovarian Cancer (HBOC) are mutations in the BRCA1 and/or BRCA2 genes. But other genes such as PALB2, CHEK2, ATM, BRIP1 and RAD51C may also increase one's risk for breast and ovarian cancer.

Topic questions include:
T1A :What is hereditary breast and ovarian cancer(HBOC)?Which are the most commonly affected genes in HBOC? 
 T1B: What information do genetic counselors need to determine risk and the need for women to be tested? 


T2A: What % of women diagnosed with #BC have these mutations? What % with #ovca have these mutations?
T2B: Has the number of prophylactic surgeries increased in the past 10 years? Have celebrity stories about their surgeries  helped or hindered? 


T3: What options do women with a BRCA mutation (Previvors) have to reduce their risk of the diseases? How will the new USPSTF recommendations impact women? 


T4: What is the best way to communicate to women with a mutation regarding their increased risk of breast and ovarian cancers? Patients: who shared this info with you? 


T5: If you had genetic testing what reaction did you have when you learned you had or did not have a BRCA mutation? 

Read more about these genetic connections on the FORCE website at:
https://www.facingourrisk.org/understanding-brca-and-hboc/information/hereditary-cancer/hereditary-genetics/basics/signs-of-hereditary-breast-and-ovarian-cancer.php#text

Learn more about genetic testing and the role of the genetic counselor on the NSGC site at:
http://aboutgeneticcounselors.com/

If you are a previvor, survivor, caregiver or you work with gyn cancer or breast cancer patients, we look forward to having you join us on Wednesday, September 11th at 9pmET!

See you then,

Dee
#gyncsm co-founder and co-moderator

Wednesday, July 11, 2018

Hereditary vs Somatic Mutations July 2018 Chat

Tonight our topic was Hereditary vs Somatic Mutations in gynecologic cancers. Along with our regular participants we also welcomed a few new community members. We especially appreciate the attendance of Erica Bodner (@EMBOSU), a genetic counselor at MD Anderson Cancer Center for sharing her expertise on hereditary mutations and the role of genetic counselors.

You may find a complete transcript here and analytics here. The resources shared during the chat are listed at the end of this post.

Here is a sample of the responses to the questions we asked during the hour chat.

T1: What is the difference between hereditary mutations and somatic mutations?
  • hereditary mutations (aka germline) = changes or "spelling mistakes" in a gene that we inherit from a parent. The mutation is present in every cell of our body. Somatic mutations are what I think of as tumor-specific: changes that occur in the tumor or cancer
  • “When a mutation occurs within germ cells, it is called a germline mutation. Germline mutations affect every cell in an organism and are passed on to offspring. When a mutation occurs in a somatic cell, it is called a somatic mutation.”
  • There are some tricky cases where we look at a tumor for it's somatic mutations and accidentally find hereditary (germline) changes -- since those are in all of the cells, often including the tumor. It can get complicated!
T2: Which gene mutations are known to be associated with hereditary gynecologic cancers?
    • 1) a single gene is like a very long sentence...a mutation=a letter change somewhere within that sentence that causes the sentence to not make any sense to the body. There can be 100s of spots in any given gene that can have a mutation
    • (2): for gyn cancers it's often easier to think about which cancers are linked to which hereditary conditions. Ex: ~3% of endometrial cancers are due to Lynch syndrome (caused by a mutation in 1 of 5 genes: MLH1 MSH2 MSH6 PMS2 or EPCAM)
    • (3) about 10-20% of "epithelial" ovarian cancers are due to a hereditary cause...most often a mutation in BRCA1 or BRCA2, but sometimes can be due to a mutation in a Lynch syndrome gene or a "moderate penetrance" gene like RAD51D
    • Genetic mutation an alteration in DNA occurs after conception ovarian CA inherited mutation in BRCA1/BRCA2
    • Yes. BRCA associated ovarian cancers are more frequently high grade serous carcinomas whereas Lynch syndrome associated ovarian carcinomas are nonserous (most endometrioid or clear cell)
    • BRCA1 and BRCA2
      T3: What testing is needed to find hereditary mutations?
          T3 follow-up... What are the differences between clinical genetic tests and Direct To Consumer (DTC) tests?
          • T3 (1) clinical genetic tests are ordered by your genetic counselor and/or doctor for medical purposes + have high levels of quality control & regulation. DTC labs (historically) have been tests ordered by any1 from home + often used different technology+ non-med purpose
          • 2) now we're starting to see clinical-DTC Hybrids like @Color that are a little bit of both. The genetic testing area is growing & changing very fast...luckily it's our job as genetic counselors to keep track of what's out there & can help navigate you to best options
          • T3: There have been many articles recently about what DTC do and do not cover. Most would need a clinical lab test to confirm results. Genetic counseling key before to decide and after to be sure understand results
          • Evaluation of some direct-to-consumer genetic testing reveals inaccuracies and misinterpretations #gyncsm http://www.facingourrisk.org/XRAYS/inaccurate-dtc-results?utm_source=social&utm_medium=social&utm_campaign=XRAYS%202017-2018%20social%20monitoring
          • Cannot be overemphasized the importance of having ur health care team involved. Confirming DTC results in a clinical laboratory that's well versed in complex variant detection & classification is essential. This is concerning... https://www.nature.com/articles/gim201838
          T4: Do we know what somatic mutations are prevalent in gynecologic cancers?
          • I found this journal article "13 most important genes for gynaecological cancers, being BRAF, CDKN2A, CTNNB1, FBXW7, FGFR2, FGFR3, FOXL2, HRAS, KRAS, NRAS, PIK3CA, PPP2R1A and PTEN." http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093451
          • Research on somatic mutations is early but is part of the personalized/precision medicine puzzle. BRAF, KRAS, PIK3CA and PTEN have been identified with epithelial ovarian tumors. There are also somatic BRCA mutations. 
           T5: How does knowing you have these mutations impact your healthcare decisions?
            • knowing if you have a hereditary mutation (or not) can impact cancer treatment decision making, cancer screening/prevention options, and can provide info to relatives so they can better understand their cancer risks
            • hereditary mutations can signal risk for other, separate cancers... This can be information to help guide screening and prevention (but the info might also feel like a burden, especially if you are already dealing with one cancer dx).
            • For those already diagnosed, more and more research is coming out to help select the best treatment based on which mutations are present. Genetic and tumor tests can help decide what to try when standard tx doesn't work - or even what to try first.
            • Do you chose prophylactic surgery? Vigilant testing ? #gyncsm. Tough choices
            • Women w/ OC knowing they are BRCA allows for additional treatment options on - PARP for example
            • Knowing that you are at risk for a certain cancers can be powerful information that allows you to take preventative risk reduction measures against developing those cancers
              T6: What role do genetic counselors play in helping patients understand the results of testing?
                • My personal bias is to hope that genetic counselors have good relationships with mental health professionals to refer patients to.
                • Personal risk is discussed. Choices are discussed. Emotional support is discussed. Information is powerful in making best decisions
                • Genetic counseling can be especially important as multi-gene panel might be better suited given your family history (vs testing for one type of mutation).
                • Genetic counselors can help you to navigate and piece together how your cancer history+family history impact your chance to have a hereditary mutation. We can help figure out if the testing you had was hereditary (germline) or somatic.
                • Genetic counselors can help you weigh pro's and con's of genetic testing, and what results could mean for you and your family. Where to get tested? Does insurance cover it? We can help with that too!
                • We can help explain your results, develop a plan for you and your family to help #endcancer. We also want to be a resource - emotional, informational, and for your family. You can find one of us at http://www.nsgc.org @GeneticCouns


                  If you are a patient or caregiver you may continue this discussion on the Smart Patients Platform https://www.smartpatients.com/gyncsm ). 

                  We hope you will join us for the next #gyncsm chat: Wednesday, August 8, 2018 on "What is OK during treatment?" where we'll touch on things like vitamins, supplements, exercise, etc.
                  Have a good month.

                  Dee
                  #gyncsm Co-moderator


                  RESOURCES
                  Germline vs Somatic mutations
                  https://biologywise.com/germline-mutation-vs-somatic-mutation

                  National Society of Genetic Counselors
                  https://www.nsgc.org/

                  FORCE
                  http://www.facingourrisk.org/understanding-brca-and-hboc/getting-tested.php
                  http://www.facingourrisk.org/XRAYS/inaccurate-dtc-results?utm_source=social&utm_medium=social&utm_campaign=XRAYS%202017-2018%20social%20monitoring

                  SGO
                  https://www.sgo.org/newsroom/position-statements-2/genetic-testing-for-gynecologic-cancer/

                  Salon - What Genetic Testing Didn't Tell Me About My Cancer
                  https://www.salon.com/2018/06/24/what-genetic-testing-didnt-tell-me-about-my-cancer/

                  CURE Magazine - Cancer Redefined Personalized Medicine
                  https://www.curetoday.com/community/rick-boulay/2018/07/cancer-redefined-personalized-medicine

                  NATURE - False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care
                  https://www.nature.com/articles/gim201838

                  New York Times - The Online Gene Test Finds a Dangerous Mutation...
                  https://www.nytimes.com/2018/07/02/health/gene-testing-disease-nyt.html?nytmobile=0

                  @NIH Fact Sheet
                  https://www.genome.gov/pages/health/patientspublicinfo/genetictestingfactsheet.pdf

                  Designing a High-Throughput Somatic Mutation Profiling Panel Specifically for Gynaecological Cancers
                  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093451

                  Friday, July 6, 2018

                  July 11, 2018 Hereditary vs Somatic Mutations


                  The topic of the #gyncsm community's second ever chat was Genetics and Personalized Medicine. Since that day in October 2013 we have learned much more about the mutations associated with gynecologic cancer. This month we will be discussing Hereditary vs Somatic Mutations.

                  If you want to know...
                  • The differences between hereditary and somatic mutations
                  • The gene mutations associated with hereditary gynecologic cancers
                  • What testing is needed to find hereditary mutations
                  • What somatic mutations are prevalent in gynecologic cancers
                  • How knowing you have these mutations can impact your healthcare decisions
                  • What role genetics counselors play in understanding test results
                  ...then be sure to join us on Wednesday July 11, 2018 at 9pm ET

                  The CDC has a wealth of information on genes and genetics at https://www.genome.gov/education/ or check out this Fact Sheet from the NIH  https://www.genome.gov/pages/health/patientspublicinfo/genetictestingfactsheet.pdf

                  We look forward to having you join us on the 11th. 

                  Dee